Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article numbere23040
JournalOncoImmunology
Volume2
Issue number2
DOIs
Publication statusPublished - 2013

Cite this